Quantcast

Latest Ketones Stories

2014-10-23 16:25:56

Entrenchment of Current Analgesics and Increasing Cost Sensitivity Will Hamper Uptake of Emerging Acute Pain Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 23, 2014 /PRNewswire/ -- Decision Resources Group finds that the acute pain market will grow minimally from $12.7 billion in 2013 to $13.3 billion in 2023 across the major pharmaceutical markets (United States, France, Germany, Italy, Spain, the United Kingdom and Japan), representing an annual...

2014-10-22 08:32:56

Pain Insights, Inc. releases a comprehensive market research study on the impact of hydrocodone rescheduling, Zohydro(TM) ER, and abuse-deterrent formulations on prescribers and the pain market. FAIRFIELD, N.J., Oct. 22, 2014 /PRNewswire/ -- Rescheduling of hydrocodone combination products (HCPs) will impel a major transformation in the pain market, according to a new primary market research study by Pain Insights, Inc., a firm providing market research and consultation exclusively in the...

2014-10-21 16:23:06

DUBLIN, October 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wwkpt5/global_isophorone) has announced the addition of the "Global Isophorone Industry Report 2014" [http://www.researchandmarkets.com/research/wwkpt5/global_isophorone ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Global Isophorone Industry Report 2014 is a professional and in-depth study on...

2014-10-21 08:33:43

Company's new identity to reflect its enhanced focus in chronic diseases of addiction RICHMOND, Va., Oct. 21, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) today announced its UK-based parent company, Reckitt Benckiser Group plc (RB), expects the proposed demerger of the RBP business to complete in 2014. Reckitt Benckiser originally announced plans to demerge the RBP business in late July 2014, and the operational and financial separations, appointment of the new...

2014-10-20 16:27:23

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Monoamine Transporter 2 compound, NBI-98854. The design of the Kinect 3 Study is a randomized, parallel-group, double-blind, placebo-controlled trial of approximately 240 subjects with moderate to severe tardive dyskinesia and an underlying diagnosis of mood disorder, schizophrenia or...

2014-10-16 08:31:24

Additional Capital Enable Company to Achieve Additional Milestones in its Business Plan NEW YORK, Oct. 16, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today the issuance of approximately 10.1 million of its shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with private placements that closed in May and June 2014. The warrants...

2014-10-15 08:30:56

- Orexigen expects to end 2014 with approximately $190 million in cash, cash equivalents and marketable securities SAN DIEGO, Oct. 15, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq:OREX) today announced it has earned a $70 million milestone payment from partner Takeda Pharmaceuticals related to the shipment of Contrave® (naltrexone HCI and bupropion HCI extended release) to pharmacy wholesalers in preparation for commercial launch. The milestone is payable within 30 days of...

2014-10-13 23:00:35

PAINWeekEnd Irvine presents a full day of pain management CME and takes place on Saturday, October 25 at the Irvine Marriott. Montclair, NJ (PRWEB) October 14, 2014 There are 116 million people in pain. There are 4,000 pain specialists. That’s 29,000 patients per pain specialist. There are simply not enough pain specialists to go around. What can primary care clinicians do to meet the challenges of this growing public health issue? Attend PAINWeekEnd Irvine on Saturday, October 25, at...

2014-10-13 20:22:44

BOCA RATON, Fla., Oct. 13, 2014 /PRNewswire/ -- TransMedia Group said it will publicize and market book rights and the completed movie script based on the true story behind the $40 million pill mill scheme operating out of pain management clinics in South Florida from 2008 to 2011. The script titled "Prescription For Death" tells how identical twins Christopher and Jeffrey George, now serving lengthy prison sentences, pulled off the nation's largest pill mill operation that killed...

2014-10-07 23:01:09

Position Statement Authored by American Academy of Clinical Toxicology, American College of Medical Toxicology and American Association of Poison Control Centers Alexandria, VA (PRWEB) October 07, 2014 On Oct. 6, 2014, the American Association of Poison Control Centers (AAPCC), joined with the American Academy of Clinical Toxicology (AACT) and American College of Medical Toxicology (ACMT), to jointly publish a position statement advocating expanding the access to naloxone throughout the...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related